Geneos Wealth Management’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$975K Sell
8,884
-1,500
-14% -$170K 0.02% 518
2025
Q4
$1.18M Buy
10,384
+1,315
+14% +$149K 0.03% 456
2025
Q3
$995K Hold
9,069
0.03% 491
2025
Q2
$940K Sell
9,069
-5,473
-38% -$550K 0.02% 549
2025
Q1
$1.51M Buy
14,542
+10,275
+241% +$1.1M 0.02% 555
2024
Q4
$444K Sell
4,267
-186
-4% -$20.2K 0.02% 623
2024
Q3
$498K Buy
4,453
+950
+27% +$104K 0.02% 565
2024
Q2
$366K Sell
3,503
-350
-9% -$36.8K 0.02% 566
2024
Q1
$422K Sell
3,853
-505
-12% -$53.4K 0.02% 526
2023
Q4
$451K Sell
4,358
-891
-17% -$85.9K 0.02% 509
2023
Q3
$510K Sell
5,249
-742
-12% -$77K 0.03% 459
2023
Q2
$649K Buy
5,991
+21
+0.4% +$2.25K 0.03% 409
2023
Q1
$642K Hold
5,970
0.04% 391
2022
Q4
$649K Hold
5,970
0.04% 364
2022
Q3
$580K Sell
5,970
-2,338
-28% -$246K 0.04% 365
2022
Q2
$871K Sell
8,308
-98
-1% -$10.6K 0.04% 355
2022
Q1
$963K Sell
8,406
-314
-4% -$35.2K 0.04% 367
2021
Q4
$1.08M Sell
8,720
-760
-8% -$91K 0.04% 376
2021
Q3
$1.12M Sell
9,480
-322
-3% -$39.4K 0.04% 348
2021
Q2
$1.16M Sell
9,802
-551
-5% -$62.9K 0.05% 327
2021
Q1
$1.19M Sell
10,353
-1,261
-11% -$138K 0.03% 381
2020
Q4
$1.25M Sell
11,614
-1,043
-8% -$106K 0.05% 300
2020
Q3
$1.17M Buy
12,657
+1,070
+9% +$100K 0.06% 264
2020
Q2
$1.02M Buy
11,587
+176
+2% +$15.1K 0.06% 281
2020
Q1
$810K Sell
11,411
-828
-7% -$67.3K 0.05% 283
2019
Q4
$1.03M Sell
12,239
-1,165
-9% -$92.3K 0.06% 293
2019
Q3
$983K Sell
13,404
-569
-4% -$43.4K 0.06% 276
2019
Q2
$1.08M Sell
13,973
-461
-3% -$34.3K 0.07% 263
2019
Q1
$1.1M Buy
14,434
+2,197
+18% +$164K 0.07% 260
2018
Q4
$829K Buy
12,237
+865
+8% +$65.5K 0.06% 278
2018
Q3
$965K Buy
11,372
+1,179
+12% +$94.1K 0.06% 262
2018
Q2
$756K Buy
10,193
+131
+1% +$9.47K 0.06% 265
2018
Q1
$698K Buy
10,062
+602
+6% +$43.4K 0.06% 258
2017
Q4
$660K Buy
9,460
+1,115
+13% +$76.2K 0.06% 272
2017
Q3
$562K Buy
8,345
+1,276
+18% +$85.2K 0.06% 283
2017
Q2
$472K Sell
7,069
-550
-7% -$35.3K 0.05% 303
2017
Q1
$475K Buy
7,619
+340
+5% +$20.8K 0.05% 288
2016
Q4
$417K Sell
7,279
-810
-10% -$46.9K 0.06% 284
2016
Q3
$492K Sell
8,089
-1,648
-17% -$100K 0.07% 247
2016
Q2
$576K Buy
9,737
+297
+3% +$17.2K 0.08% 222
2016
Q1
$532K Buy
+9,440
New +$510K 0.08% 225

Other funds holding FXH

Geneos Wealth Management's FXH Position: Q1 2026 in Review

Geneos Wealth Management reduced its First Trust Health Care AlphaDEX Fund (FXH) stake by 14% in Q1 2026, selling an estimated $170K and leaving 8,884 shares worth $975K. The position accounts for 0.02% of the portfolio, ranked #518.

Geneos Wealth Management first reported a position in FXH in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.51M in Q1 2025. 238 funds tracked by Wall St. Rank hold FXH as of Q1 2026.

  • Geneos Wealth Management held 8,884 shares of First Trust Health Care AlphaDEX Fund worth $975K as of Q1 2026.
  • Geneos Wealth Management sold 1,500 First Trust Health Care AlphaDEX Fund shares in Q1 2026, an estimated $170K.
  • First Trust Health Care AlphaDEX Fund made up 0.02% of Geneos Wealth Management's portfolio in Q1 2026, its #518 holding.
  • Geneos Wealth Management first reported a position in First Trust Health Care AlphaDEX Fund in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's First Trust Health Care AlphaDEX Fund position peaked at $1.51M in Q1 2025.
  • 238 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.